Experimental Antitumour Activity of S 16020-2 in a Panel of Human Tumours

By Kraus-Berthier L.   Guilbaud N.   Jan M.   Saint-Dizier D.   Rouillon M.H.   Burbridge M.F.   Pierre A.   Atassi G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1881-1887

Elsevier

Access to resources Recommend Favorite

The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts

By Breistol K.   Hendriks H.R.   Berger D.P.   Langdon S.P.   Fiebig H.H.   Fodstad O.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1602-1606

Elsevier

Access to resources Recommend Favorite

Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts

By Langdon S.P.   Ritchie A.A.   Muir M.   Dodds M.   Howie A.F.   Leonard R.C.F.   Stockman P.K.   Miller W.R.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 384-388

Elsevier

Access to resources Recommend Favorite

In Vivo Bromodeoxyuridine Labelling in Human Tumour Xenografts

By Parkins C.S.   Begg A.C.   Bush C.   Price P.   Imrie P.R.   Ormerod M.G.   Steel G.G.  

International Journal of Radiation Biology, Vol. 56, Iss. 5, 1989-11 ,pp. : 787-791

Informa Healthcare

Access to resources Recommend Favorite

The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O 6 -alkylguanine-DNA-alkyltransferase of human tumour xenografts

By D'Incalci M.   Bonfanti M.   Pifferi A.   Mascellani E.   Tagliabue G.   Berger D.   Fiebig H.H.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1749-1755

Elsevier

Access to resources Recommend Favorite